Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Holcim (HOLN.S)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (CHF) Price Target (CHF) Rating
2022-03-1144.1358.00Buy
2022-04-0742.5054.00Buy
2022-04-2247.5655.00Buy
2022-06-2742.8145.00Neutral
2022-10-2845.0146.00Neutral
2023-01-2653.2051.00Neutral
2023-03-1057.9263.00Neutral
2023-07-0756.4060.50Neutral
2023-09-1157.0661.00Neutral
2024-01-2363.2666.00Neutral
2024-03-1276.9080.00Neutral
2024-03-2680.9281.00Neutral
2024-07-0179.9080.00Neutral
2024-09-2383.0085.00Neutral
2025-01-1685.4689.00Neutral
2025-04-2490.4088.00Neutral

Disclosures

  • UBS Australia is advising Cement Australia and its shareholders, Holcim Australia and Heidelberg Materials Australia, to acquire the cementitious division of Buckeridge Group of Companies (BGC) and will receive a fee for acting in this capacity. Holcim Australia is a subsidiary of Holcim Ltd and Heidelberg Materials Australia is a subsidiary of Heidelberg Materials AG.
  • Within the past 12 months, UBS has received compensation for investment banking services from this company/entity or one of its affiliates.
  • UBS expects to receive or intend to seek compensation for investment banking services from this company/entity within the next three months.
  • This company/entity is, or within the past 12 months has been, a client of UBS Securities LLC, and investment banking services are being, or have been, provided.
  • Within the past 12 months, UBS has received compensation for products and services other than investment banking services from this company/entity.
  • UBS beneficially owned 1% or more of a class of this company`s common equity securities as of last month`s end (or the prior month`s end if this report is dated less than 10 days after the most recent month`s end).
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 15% above the MRA for a Buy rating, and at -15% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
  • UBS Fund Management (Switzerland) AG beneficially owns more than 5% of the total issued share capital of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.